HERPES ZOSTER (HZ)
Clinical trials for HERPES ZOSTER (HZ) explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER (HZ) trials appear
Sign up with your email to follow new studies for HERPES ZOSTER (HZ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shingles vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine called JCXH-105 in healthy adults aged 50 and older. It compares the new vaccine to the current standard, Shingrix, to see if it is safe and triggers a strong immune response. About 467 participants will receive either JCXH-105 or Shingrix,…
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New shingles vaccine candidate enters Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine called LYB004 in 840 adults aged 40 and older in China. Participants receive one of four different doses of the vaccine or a placebo. The goal is to see how well the vaccine triggers an immune response and whether it is safe.
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:07 UTC